Filed in archive
Developments
, News
, Treatment
on November 5, 2010
KOMBIGLYZE™ XR - product of Bristol-Myers Squibb and AstraZeneca - got US FDA approval as treatment of type 2 diabetes in adults.
The first and only once-a-day metformin extended-release (XR) plus ...
Filed in archive
Developments
, Notable
, Research
on October 26, 2010
According to a new mice study led by researchers from the National Taiwan University, polyunsaturated fatty acid (PUFA) fish oils may activate genes that regulate fat cell differentiation and glucose ...
Filed in archive
Developments
, Research
on August 8, 2010
In the absence of a cure for cognitive impairment, researchers have recently found that interventions for diabetes prevention could be an effective way of reducing dementia.
Karen Ritchie, PhD (Fre...
Filed in archive
Developments
, Diabetics' Device
on June 7, 2010
Photo CreditThere is a misconception among both healthcare professionals and people living with diabetes that a person's body type or body mass index (BMI) dictates whether they need a longer need...
Filed in archive
Developments
, Research
, Treatment
on April 14, 2010
In type 1 diabetes, the pancreas doesn't produce enough insulin to control blood sugar levels.
Now, a study and editorial published online April 14 in Science Translational Medicine reported th...
Filed in archive
Developments
, Research
on April 11, 2010
Type 1 diabetes or juvenile diabetes is an autoimmune disease. The white blood cells called T cells attack the insulin-producing beta cells in the pancreas. Such is the case also in diseases like lupu...
Filed in archive
Developments
, Did you know
, Research
, Treatment
on April 8, 2010
Diabetic macular edema is a complication of diabetes that, if left untreated, may result to vision impairment, blurriness, or blindness in diabetic patients. Currently, the standard of treatment for d...
Filed in archive
Developments
, Notable
, Research
on August 7, 2009
A study performed at Massachusetts General Hospital and Harvard Medical School in Boston suggests that a noninvasive imaging (MRI) may aid physicians in the early diagnosis, staging and treatment of ...
Filed in archive
Developments
, Research
, Treatment
on July 30, 2009
African Americans are 1.6 times more likely to have diabetes than non-Hispanic whites, and almost 15% of all African Americans aged 20 years or older have diabetes. On top of this, despite the wide ra...
Filed in archive
Developments
, Treatment
on June 14, 2009
Novo Nordisk has a new diabetes drug under clinical trials - Victoza (liraglutide) - that is proving much better than Byetta (exenatide).
From WebMD:
Byetta is the first of the class of type 2 diab...
Most Popular
Best of
Blogs, Blogging & Blogosphere
Challenges
Developments
Diabetics' Device
Did you know
Diet
Education
Exercise
Family Matters
Friends
Fun
Information
Information about
Inspiration
Interviews
Lifestyle
Misc
News
Notable
